ByHeart has acquired a manufacturing facility in Allerton, Iowa, to enhance its production capacity and meet the growing demand for high-quality infant formula.

Target Information

ByHeart, a next-generation baby nutrition company founded in 2016 and headquartered in New York City, is dedicated to empowering parents with innovative feeding solutions. The company has made significant strides in the infant formula market, providing products that adhere to the highest nutritional standards and are free from additives like corn syrup and soy. Its unique clinical research supports the effectiveness of its infant formula, distinguished by a patented protein blend that closely resembles breast milk.

As of January 25, 2023, ByHeart has announced the acquisition of a manufacturing facility in Allerton, Iowa, from DairiConcepts, aiming to further enhance its production capabilities. This acquisition, combined with its existing facilities, positions ByHeart to meet the nutritional needs of approximately 500,000 infants annually.

Industry Overview

The infant formula industry in the United States has been historically dominated by three major players, controlling 90% of the market. This has led to a lack of competition and innovation within the

View Source

Similar Deals

HALO Dream Inc. Baby Merlin

2025

Other Private Equity Child Care & Family Services United States of America
The Wine Group Constellation Brands

2025

Other Private Equity Wineries United States of America
Altas Partners Redwood Services

2025

Other Private Equity Consumer Repair Services United States of America
Crown Laboratories, Inc. Revance Therapeutics, Inc.

2025

Other Private Equity Cosmetics & Perfumes United States of America
Entrepreneurial Equity Partners Bil-Jac Foods

2025

Other Private Equity Pet Food Manufacturing United States of America
Northleaf Capital Partners and AVALT WASH Multifamily Holdings Inc.

2025

Other Private Equity Consumer Goods Rental United States of America

ByHeart

invested in

DairiConcepts Allerton Facility

in 2023

in a Other Private Equity deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert